Skip to main content
. 2018 Feb 14;24(6):671–679. doi: 10.3748/wjg.v24.i6.671

Table 4.

Comparison of responses in patients with and without carcinoid syndrome in the HRQoL QLQ-GI.NET21 questionnaire

Without carcinoid syndrome
With Carcinoid syndrome
Difference between groups P value
Mean score (95%CI) Mean score (95%CI)
Endocrine symptoms 16.7 8.4-24.9 28.4 18.1-38.8 -11.8 0.04
Gastrointestinal symptoms 18.9 12.7-25.3 24.0 16.5-31.5 -5.1 0.37
Treatment-related symptoms 17.5 8.6-26.4 10.1 4.1-16.2 7.4 0.20
Social functioning 60.0 50.0-70.0 68.4 58.7-78.1 -8.4 0.19
Disease-related worries 56.9 43.0-70.8 38.7 26.2-51.2 18.2 0.05
Body image 15.3 4.3-26.2 13.3 2.1-24.6 1.9 0.57
Weight gain 18.7 7.4-30.0 13.3 2.1-24.6 5.3 0.30
Muscle/bone pain 41.3 28.6-54.1 46.7 31.3-62.1 -5.3 0.62
Information 10.7 2.0-19.3 16.0 4.7-27.3 -5.3 0.51
Sexual functioning 60.8 35.6-85.9 68.4 47.4-89.5 -7.6 0.82